Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • mnandita
    Junior Member
    • Dec 2011
    • 7

    Starting concentration of sample/control in ChIP Seq

    Given the little amounts of DNA obtained after ChIP, are analysis algorithms equipped to normalize data across input/mock/test ips if different amounts of starting material were used in each case to make the libraries?

    So if i have 10 ng of IP test, but 40 ng of input and 100 ng of mock, should I necessarily make all libraries from 10 ng only, or can I take all the DNA I have for each of the experiments?
  • ETHANol
    Senior Member
    • Feb 2010
    • 308

    #2
    You should absolutely use the smallest amount of DNA from your samples in all your libraries. In your example that would be 10 ng. The main reason is because PCR induces biases with each cycle (exponentially I believe), so if you are amplifying one sample less then other, the PCR bias won't be transferred equally between them.

    More simply, samples should be treated equally, to do that you need to use the same amount of starting material.

    One other thing, mock IP isn't really a good control. Just use input and your ChIP.
    --------------
    Ethan

    Comment

    • mnandita
      Junior Member
      • Dec 2011
      • 7

      #3
      Thanks Ethan. I agree with that (reg. starting with same amounts).

      As for the mock control- if your Ab is not very good, and there is sufficient amount of non-specific DNA pull down that does not show up in the input, how do you control for it without a mock? I do not think the mock is dispensable, except in cases where you have a very specific Ab.
      Last edited by mnandita; 12-15-2011, 10:04 AM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Working...